{
  "config": {
    "clinical_question": "Compare the effectiveness of letrozole+palbociclib with letrozole+ribociclib for the first line treatment of metastatic ER positive breast cancer.",
    "dataset_size": 1000,
    "treatment_coefficient": 1.0,
    "target_treatment_rate": 0.5,
    "target_control_outcome_rate": 0.2,
    "main_coefficient_scale": 0.3,
    "interaction_coefficient_scale": 0.1,
    "target_logit_std": 2.0,
    "num_confounders": null,
    "output_dir": "./example_synthetic_dataset_simple_strict",
    "llm": {
      "api_base_url": "http://localhost:8000/v1",
      "api_key": "",
      "model_name": "openai/gpt-oss-120b",
      "temperature": 0.7,
      "max_tokens": 50000,
      "timeout": 300.0
    },
    "seed": 42
  },
  "confounders": [
    {
      "name": "age",
      "type": "continuous",
      "description": "Patient age at initiation of first‑line therapy, measured in years"
    },
    {
      "name": "ecog_performance_status",
      "type": "categorical",
      "categories": [
        "0",
        "1",
        "2",
        "3"
      ],
      "description": "Eastern Cooperative Oncology Group performance status score at baseline"
    },
    {
      "name": "menopausal_status",
      "type": "categorical",
      "categories": [
        "pre‑menopausal",
        "peri‑menopausal",
        "post‑menopausal"
      ],
      "description": "Menopausal state at the start of treatment"
    },
    {
      "name": "visceral_metastasis_site",
      "type": "categorical",
      "categories": [
        "bone‑only",
        "lung",
        "liver",
        "brain",
        "multiple_viscera"
      ],
      "description": "Location of metastatic disease involving visceral organs"
    },
    {
      "name": "prior_adjuvant_endocrine_therapy",
      "type": "categorical",
      "categories": [
        "none",
        "tamoxifen_only",
        "aromatase_inhibitor_only",
        "sequential_tamoxifen_then_AI",
        "other"
      ],
      "description": "Type of endocrine therapy received in the adjuvant setting before recurrence"
    },
    {
      "name": "comorbidity_index",
      "type": "continuous",
      "description": "Charlson comorbidity index score reflecting overall burden of non‑cancer comorbidities"
    },
    {
      "name": "baseline_liver_function_alt",
      "type": "continuous",
      "description": "Serum alanine aminotransferase (ALT) level at baseline, expressed in U/L"
    },
    {
      "name": "baseline_neutrophil_count",
      "type": "continuous",
      "description": "Absolute neutrophil count at baseline, expressed in 10^9/L"
    },
    {
      "name": "body_mass_index",
      "type": "continuous",
      "description": "Body mass index (kg/m²) measured within 30 days prior to therapy start"
    },
    {
      "name": "prior_metastatic_chemotherapy",
      "type": "categorical",
      "categories": [
        "none",
        "one_line",
        "two_or_more_lines",
        "unknown"
      ],
      "description": "Number of chemotherapy lines received for metastatic disease before initiating the CDK4/6‑inhibitor regimen"
    }
  ],
  "treatment_equation": {
    "intercept": 0.1848392001989323,
    "coefficients": {
      "age": 1.1323311157725189,
      "comorbidity_index": -0.6793986694635112,
      "baseline_liver_function_alt": -0.45293244630900753,
      "baseline_neutrophil_count": 0.22646622315450377,
      "body_mass_index": 0.0905864892618015,
      "ecog_performance_status_1": -1.3587973389270225,
      "ecog_performance_status_2": -2.717594677854045,
      "ecog_performance_status_3": -4.076392016781068,
      "menopausal_status_peri-menopausal": 0.45293244630900753,
      "menopausal_status_post-menopausal": 0.9058648926180151,
      "visceral_metastasis_site_lung": -0.22646622315450377,
      "visceral_metastasis_site_liver": -0.9058648926180151,
      "visceral_metastasis_site_brain": -1.3587973389270225,
      "visceral_metastasis_site_multiple_viscera": -0.6793986694635112,
      "prior_adjuvant_endocrine_therapy_tamoxifen_only": 0.22646622315450377,
      "prior_adjuvant_endocrine_therapy_aromatase_inhibitor_only": -0.45293244630900753,
      "prior_adjuvant_endocrine_therapy_sequential_tamoxifen_then_AI": 0.0,
      "prior_adjuvant_endocrine_therapy_other": 0.0905864892618015,
      "prior_metastatic_chemotherapy_one_line": -1.1323311157725189,
      "prior_metastatic_chemotherapy_two_or_more_lines": -2.2646622315450378,
      "prior_metastatic_chemotherapy_unknown": -0.45293244630900753
    },
    "interactions": [
      {
        "terms": [
          "age",
          "comorbidity_index"
        ],
        "coefficient": -0.12078198568240202
      },
      {
        "terms": [
          "menopausal_status_post-menopausal",
          "visceral_metastasis_site_liver"
        ],
        "coefficient": -0.181172978523603
      },
      {
        "terms": [
          "prior_adjuvant_endocrine_therapy_aromatase_inhibitor_only",
          "prior_metastatic_chemotherapy_one_line"
        ],
        "coefficient": -0.10568423747210177
      }
    ],
    "original_intercept": -0.4
  },
  "outcome_equation": {
    "intercept": -1.7089213762008795,
    "coefficients": {
      "age": -0.5472544046383258,
      "comorbidity_index": 0.8208816069574886,
      "baseline_liver_function_alt": 0.6840680057979072,
      "baseline_neutrophil_count": -0.2736272023191629,
      "body_mass_index": 0.13681360115958144,
      "ecog_performance_status_1": 1.0945088092766515,
      "ecog_performance_status_2": 2.189017618553303,
      "ecog_performance_status_3": 3.557153630149118,
      "menopausal_status_peri-menopausal": 0.13681360115958144,
      "menopausal_status_post-menopausal": 0.2736272023191629,
      "visceral_metastasis_site_lung": 0.8208816069574886,
      "visceral_metastasis_site_liver": 1.6417632139149771,
      "visceral_metastasis_site_brain": 2.462644820872466,
      "visceral_metastasis_site_multiple_viscera": 1.231322410436233,
      "prior_adjuvant_endocrine_therapy_tamoxifen_only": -0.13681360115958144,
      "prior_adjuvant_endocrine_therapy_aromatase_inhibitor_only": 0.0,
      "prior_adjuvant_endocrine_therapy_sequential_tamoxifen_then_AI": 0.05472544046383258,
      "prior_adjuvant_endocrine_therapy_other": 0.08208816069574885,
      "prior_metastatic_chemotherapy_one_line": 0.5472544046383258,
      "prior_metastatic_chemotherapy_two_or_more_lines": 1.231322410436233,
      "prior_metastatic_chemotherapy_unknown": 0.2736272023191629
    },
    "interactions": [
      {
        "terms": [
          "age",
          "menopausal_status_post-menopausal"
        ],
        "coefficient": -0.045604533719860486
      },
      {
        "terms": [
          "visceral_metastasis_site_liver",
          "prior_adjuvant_endocrine_therapy_aromatase_inhibitor_only"
        ],
        "coefficient": 0.13681360115958144
      },
      {
        "terms": [
          "comorbidity_index",
          "baseline_neutrophil_count"
        ],
        "coefficient": 0.07296725395177676
      }
    ],
    "treatment_coefficient": 1.0,
    "treatment_interactions": [
      {
        "term": "age",
        "coefficient": -0.22886157522060582
      },
      {
        "term": "ecog_performance_status_1",
        "coefficient": 0.822184631387782
      },
      {
        "term": "ecog_performance_status_2",
        "coefficient": 0.423199021685663
      },
      {
        "term": "ecog_performance_status_3",
        "coefficient": 0.17997096677256313
      },
      {
        "term": "menopausal_status_peri‑menopausal",
        "coefficient": -0.6274843804378543
      },
      {
        "term": "menopausal_status_post‑menopausal",
        "coefficient": -0.627528379885777
      },
      {
        "term": "visceral_metastasis_site_lung",
        "coefficient": -0.8061356324093716
      },
      {
        "term": "visceral_metastasis_site_liver",
        "coefficient": 0.6679716954960632
      },
      {
        "term": "visceral_metastasis_site_brain",
        "coefficient": 0.1844521185050902
      },
      {
        "term": "visceral_metastasis_site_multiple_viscera",
        "coefficient": 0.379562115611122
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_tamoxifen_only",
        "coefficient": -0.8745408238284418
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_aromatase_inhibitor_only",
        "coefficient": 0.857200787928653
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_sequential_tamoxifen_then_AI",
        "coefficient": 0.606435664892092
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_other",
        "coefficient": -0.5247456290783044
      },
      {
        "term": "comorbidity_index",
        "coefficient": -0.5804089604728598
      },
      {
        "term": "baseline_liver_function_alt",
        "coefficient": -0.5775275882377934
      },
      {
        "term": "baseline_neutrophil_count",
        "coefficient": -0.3570976492750407
      },
      {
        "term": "body_mass_index",
        "coefficient": 0.04516022084623245
      },
      {
        "term": "prior_metastatic_chemotherapy_one_line",
        "coefficient": -0.12414462768560433
      },
      {
        "term": "prior_metastatic_chemotherapy_two_or_more_lines",
        "coefficient": -0.38083590862250655
      },
      {
        "term": "prior_metastatic_chemotherapy_unknown",
        "coefficient": 0.20403996436123037
      }
    ],
    "original_intercept": -1.2
  },
  "summary_statistics": {
    "age": {
      "type": "continuous",
      "mean": 62.5,
      "std": 11.3
    },
    "ecog_performance_status": {
      "type": "categorical",
      "proportions": {
        "0": 0.2,
        "1": 0.5,
        "2": 0.2,
        "3": 0.1
      }
    },
    "menopausal_status": {
      "type": "categorical",
      "proportions": {
        "pre-menopausal": 0.15,
        "peri-menopausal": 0.05,
        "post-menopausal": 0.8
      }
    },
    "visceral_metastasis_site": {
      "type": "categorical",
      "proportions": {
        "bone-only": 0.3,
        "lung": 0.2,
        "liver": 0.25,
        "brain": 0.05,
        "multiple_viscera": 0.2
      }
    },
    "prior_adjuvant_endocrine_therapy": {
      "type": "categorical",
      "proportions": {
        "none": 0.1,
        "tamoxifen_only": 0.3,
        "aromatase_inhibitor_only": 0.4,
        "sequential_tamoxifen_then_AI": 0.15,
        "other": 0.05
      }
    },
    "comorbidity_index": {
      "type": "continuous",
      "mean": 4.2,
      "std": 2.1
    },
    "baseline_liver_function_alt": {
      "type": "continuous",
      "mean": 32.0,
      "std": 14.5
    },
    "baseline_neutrophil_count": {
      "type": "continuous",
      "mean": 4.6,
      "std": 1.4
    },
    "body_mass_index": {
      "type": "continuous",
      "mean": 27.3,
      "std": 5.2
    },
    "prior_metastatic_chemotherapy": {
      "type": "categorical",
      "proportions": {
        "none": 0.7,
        "one_line": 0.2,
        "two_or_more_lines": 0.05,
        "unknown": 0.05
      }
    }
  },
  "dataset_statistics": {
    "n_patients": 1000,
    "treatment_rate": 0.154,
    "outcome_rate": 0.719,
    "mean_treatment_logit": -2.5852723966196307,
    "std_treatment_logit": 1.943944216284123,
    "mean_outcome_logit": 1.2845438050334774,
    "std_outcome_logit": 1.576725865121567,
    "clinical_text_stats": {
      "non_empty_count": "1000",
      "mean_length": 8618.325
    }
  }
}